查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1182123

全球口干症（口干病）治疗药物市场规模及预测：按类型、产品、分销渠道和地区分析，2022-2029 年

Global Xerostomia Therapeutics Market Size study & Forecast, by Type, Product, Distribution Channel, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

口干是一种影响口腔唾液分泌，导致口腔干燥的疾病。

这种疾病会对身体功能产生不利影响，例如进食、说话和消化。他们也可能变得营养不良并对身体产生不利影响。高剂量药物、抗抑郁药、安眠药和抗炎药是导致这些疾病的原因。市场增长受到关键因素的支持，例如在癌症治疗中越来越多地采用化学疗法和放射疗法，干燥综合征、艾滋病毒、糖尿病和阿尔茨海默氏病等疾病的患病率增加，以及老年人口的增加。

美国疾病控制与预防中心 (CDC) 估计，每年约有 650,000 名癌症患者在门诊肿瘤诊所接受化疗。此外，还有一项名为“糖尿病性口干症人工唾液（ASDIX）”的研究。2020 年 7 月发表的“Aldiamed 与安慰剂双盲研究”得出结论，Aldiamed 喷雾剂在治疗 1 型和 2 型糖尿病患者的口干方面优于安慰剂。这些研究证明了人工唾液补充剂在治疗口干症方面的有效性。然而，缺乏有效治疗方法阻碍了整个 2022-2029 年预测期内的市场增长。

全球口干症（口干病）药物市场研究中考虑的主要区域是亚太地区、北美、欧洲、中美洲和南美洲以及世界其他地区。由于口干症患病率上升、艾滋病毒感染率上升以及提高口干意识活动，北美在整体市场份额中处于领先地位。然而，由于糖尿病等疾病的患病率上升和医疗保健成本上升，预计亚太地区将成为增长最快的地区。

本研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。该报告旨在包括被调查国家工业的定性和定量方面。

它还提供了有关关键方面的详细信息，例如将定义市场未来增长的驱动因素和挑战。此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

目录

第一章执行摘要

  • 市场快照
  • 2019-2029 年按细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的口干症（口干病）药物市场
    • 2019-2029 年按类型分列的口干症（口干病）药物市场
    • 2019-2029 年按产品分列的口干症（口干病）药物市场
    • 口干症（口干病）治疗市场：按分销渠道，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第二章口干症（口干病）药物的全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 产业进化
  • 调查目标年份
  • 货币兑换率

第 3 章口干症（口干病）药物的全球市场动态

  • 口干症（口干症）药物市场影响分析（2019-2029）
    • 市场驱动力
      • 在癌症治疗中越来越多地采用化学疗法和放射疗法
      • 干燥综合征、艾滋病毒、糖尿病和阿尔茨海默病等疾病的患病率上升
      • 老年人口增加
    • 市场挑战
      • 缺乏有效的治疗方法
    • 市场机会
      • 启动研发活动
      • 增加新品引进

第四章口干症（口干病）治疗药物的全球市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争
  • 波特五力模型的未来方法（2019-2029）
  • PEST分析
    • 政治的
    • 经济的
    • 社会的
    • 技术的
  • 招商引资模式
  • 分析师结论/建议
  • 顶级投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的整体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

6. 全球口干症（口干病）治疗市场，按类型分类

  • 市场快照
  • 全球口干症（口干病）治疗市场：按类型、性能潜力分析
  • 2019-2029 年全球口干（口干病）药物市场按类型估算和预测
  • 口干症（口干病）治疗药物市场，细分分析
    • 人工唾液/唾液替代品
    • 唾液分泌兴奋剂

7 全球口干症（口干病）药物市场，副产品

  • 市场快照
  • 全球口干症（口干病）治疗药物市场：按产品分类的性能潜力分析
  • 2019-2029 年全球口干症（口干病）药物市场、按产品估算和预测
  • 口干症（口干病）治疗药物市场，细分分析
    • 药物
    • 唾液腺
    • 其他产品类型

8 全球口干症（口干病）药物市场，按分销渠道

  • 市场快照
  • 全球口干症（口干病）治疗药物市场：分销渠道的性能潜力分析
  • 2019-2029 年全球口干（口干病）治疗药物市场，按分销渠道估计和预测
  • 口干症（口干病）治疗药物市场，细分分析
    • 医院药房
    • 零售药店
    • 网上药店

9 全球口干症（口干病）药物市场：区域分析

  • 口干症（口干病）治疗药物市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按类型划分的估计和预测，2019-2029
      • 2019-2029 年各产品的估计和预测
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲口干症（口干病）药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区口干症（口干病）药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲口干症（口干病）药物市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章 竞争信息

  • 顶级市场战略
  • 公司简介
    • Lupin Limited
      • 主要信息
      • 概述
      • 财务信息（视数据可用性而定）
      • 产品概要
      • 最近的发展
    • Quest Products, Inc.
    • Parnell Pharmaceuticals, Inc.
    • Fresenius SE & Co. KGaA
    • Hikma Pharmaceuticals PLC
    • Sun Pharmaceutical Industries Ltd
    • GlaxoSmithKline PLC
    • ADVANZ PHARMA Corp. Limited
    • Pharmascience Inc
    • Synedgen, Inc.

第十一章调查过程

  • 调查过程
    • 数据挖掘
    • 分析
    • 市场估计
    • 验证
    • 出版物
  • 调查属性
  • 调查先决条件

Global Xerostomia (Dry Mouth Disease) Therapeutics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.25% over the forecast period 2022-2029. A medical disorder known as dry mouth causes the mouth to become dry by affecting saliva production in the mouth. Body functions including eating, speaking, and digestion may be negatively impacted by this disorder. Malnutrition may result from this and have a harmful effect on the body. High dosage pharmaceuticals, antidepressants, hypnotics, anti-inflammatory meds, and other substances are the cause of these diseases. The market growth is supported by significant factors such as increasing adoption of chemotherapy and radiotherapy in cancer treatment, growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others and a growing geriatric population base.

The Centers for Disease Control and Prevention (CDC) estimate that each year, around 650,000 cancer patients get chemotherapy in an ambulatory oncology clinic. Additionally, a study named "Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed Versus Placebo" that was released in July 2020 concluded that Aldiamed spray was superior to a placebo in treating xerostomia in people with type 1 and type 2 diabetes. These studies show that the use of artificial saliva replacements in the treatment of xerostomia is effective. However, the nonavailability of effective treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Xerostomia (Dry Mouth Disease) Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is leading the overall market share owing to the increasing prevalence of xerostomia and increase in HIV disease coupled with the increase in dry mouth awareness initiatives. However, Asia Pacific is expected to be the fastest growing region due to the rising prevalence of diseases such as diabetes and growing healthcare expenditure.

Major market players included in this report are:

Lupin Limited

Quest Products, Inc.

Parnell Pharmaceuticals, Inc.

Fresenius SE & Co. KGaA

Hikma Pharmaceuticals PLC

Sun Pharmaceutical Industries Ltd

GlaxoSmithKline PLC

ADVANZ PHARMA Corp. Limited

Pharmascience Inc

Synedgen, Inc.

Recent Developments in the Market:

In April 2021, Parnell Pharmaceuticals, Inc. launched the Mouth Kote-MD mouthwash based on MycoDelens, a proprietary substance created and licenced by New Mexico Tech University.

Virginia Head & Neck Therapeutics, Inc. introduced Voutia in February 2021, a medication that continuously relieves xerostomia (commonly known as chronic dry mouth). For the millions of people who experience this painful and frequently disabling illness, the unique, FDA-approved device provides a whole new strategy.

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Product, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

By Type:

Drugs

Salivary Pens

Other Product Types

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, by region, 2019-2029 (USD Billion)
    • 1.2.2. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product, 2019-2029 (USD Billion)
    • 1.2.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Dynamics

  • 3.1. Xerostomia (Dry Mouth Disease) Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing adoption of chemotherapy and radiotherapy in cancer treatment
      • 3.1.1.2. Growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others.
      • 3.1.1.3. Growing geriatric population base
    • 3.1.2. Market Challenges
      • 3.1.2.1. Nonavailability of effective treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing research and development activities
      • 3.1.3.2. Rising introduction of novel products

Chapter 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Type, Performance - Potential Analysis
  • 6.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Artificial Saliva/Saliva Substitutes
    • 6.4.2. Salivary Stimulants

Chapter 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Product, Performance - Potential Analysis
  • 7.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 7.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Drugs
    • 7.4.2. Salivary Pens
    • 7.4.3. Other Product Types

Chapter 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Xerostomia (Dry Mouth Disease) Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy

Chapter 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Analysis

  • 9.1. Xerostomia (Dry Mouth Disease) Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.2.1. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.3. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.3.1. U.K. Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.2. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.3. France Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.4. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.5. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.3.6. Rest of Europe Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.4. Asia-Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.4.1. China Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.2. India Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.3. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.4. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.5. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.5. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market Snapshot
    • 9.5.1. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 9.5.2. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market
  • 9.6. Rest of The World Xerostomia (Dry Mouth Disease) Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Lupin Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Quest Products, Inc.
    • 10.2.3. Parnell Pharmaceuticals, Inc.
    • 10.2.4. Fresenius SE & Co. KGaA
    • 10.2.5. Hikma Pharmaceuticals PLC
    • 10.2.6. Sun Pharmaceutical Industries Ltd
    • 10.2.7. GlaxoSmithKline PLC
    • 10.2.8. ADVANZ PHARMA Corp. Limited
    • 10.2.9. Pharmascience Inc
    • 10.2.10. Synedgen, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, report scope
  • TABLE 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by region 2019-2029 (USD Billion)
  • TABLE 3. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Xerostomia (Dry Mouth Disease) Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Xerostomia (Dry Mouth Disease) Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, research methodology
  • FIG 2. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, key trends 2021
  • FIG 5. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, porters 5 force model
  • FIG 7. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, pest analysis
  • FIG 8. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, value chain analysis
  • FIG 9. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Xerostomia (Dry Mouth Disease) Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Xerostomia (Dry Mouth Disease) Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Xerostomia (Dry Mouth Disease) Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable